LI Junmin, MD, PhD, 外院（External Specialist）
- Jiahui International Cancer Center
- Medical Oncology (Hematology)
- Jiahui International Hospital (Shanghai)
- Languages:普通话, English
Dr. Li Junmin, MD, PhD, currently serves as the Director of the Hematology Department at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. He holds the positions of vice president of the Hematology Branch of the Chinese Medical Doctor Association (CMDA), president of the Hematology Branch of the Chinese Geriatrics Society, chairman of the Shanghai Hematology Branch of the Chinese Medical Association (CMA), chairman of the Shanghai Hematology-Oncology Committee of the China Anti-Cancer Association, vice president of the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care, and chief scientist of the tumor mRNA vaccine key project supported by the Ministry of Science and Technology.
Pr. Li has been engaged in clinical and scientific research in the field of hematology in internal medicine for a long time. He has extensive experience in the pathogenesis and treatment of hematological malignancies and immune-related blood disorders. He has been the principal investigator for four projects funded by the National Natural Science Foundation and one key project of the Ministry of Science and Technology of the PRC. He has also successfully led an 863-Initiative research project and one special project sponsored by the Ministry of Health of the PRC. At the provincial and ministerial levels, he has undertaken five research projects, including those supported by the Ministry of Education of the PRC and the Shanghai municipality.
Pr. Li has an impressive publication record, with nearly a hundred papers published in domestic and international academic journals. Among his accolades are the prestigious National Science and Technology Award, the Ministry of Education Scientific and Technological Achievement Award, the Shanghai Science and Technology Progress Award, and the Shanghai Medical Science and Technology Award. His expertise lies in the field of hematological malignancies, focusing on diseases affecting the blood system such as leukemia, lymphoma, multiple myeloma, and immune-related blood disorders like idiopathic thrombocytopenic purpura.